<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01957098</url>
  </required_header>
  <id_info>
    <org_study_id>(KF) 11 324909</org_study_id>
    <nct_id>NCT01957098</nct_id>
  </id_info>
  <brief_title>The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man</brief_title>
  <acronym>M192</acronym>
  <official_title>The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danisco</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of L-arabinose and D-xylose in a
      sugar-rich drink on intestinal sucrase activity in healthy volunteers by measuring
      postprandial blood glucose and insulin, and selected intestinal hormonal responses to
      increasing doses of L-arabinose and D-xylose.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Based on previous scientific results we hypotesize, that pentoses decreases the demand for
      insulin in metabolizing a given dose of sucrose.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">May 2007</completion_date>
  <primary_completion_date type="Actual">January 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood glucose, insulin, C-peptide and GLP-1</measure>
    <time_frame>-15, 0, 15, 30, 45, 60, 90, 120, 180 min</time_frame>
    <description>Level of glucose, insulin, C-peptide and glucagon-like peptide-1 (GLP-1) over time, the area under the curve (AUC), the peak value and time to peak</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Appetite measurements and energy intake</measure>
    <time_frame>-15, 30, 60, 90, 120, 150 and 180 min</time_frame>
    <description>Appetite measurements: area under/over the curve (AUC/AOC), 3-h mean. Energy intake: the ad libitum energy intake at lunch was registered. VAS was used to asses the palatability (appearance, smell, taste, after-taste and overall palatability) of the ad libitum lunch.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>0% pentose</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Pure sucrose without pentoses added.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4% D-xylose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sucrose drink supplemented with 4% D-xylose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8% D-xylose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sucrose drink supplemented with 8% D-xylose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8% L-arabinose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sucrose drink supplemented with 8% L-arabinose</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo comparator: 0% pentose</intervention_name>
    <description>14 healthy subjects participated in a randomized double-blinded cross-over study based on four single tests. Sucrose containing drinks were supplemented with two different doses of D-xylose and in addition one dose of L-arabinose was included for comparison with earlier studies. Blood was collected fasting and for 3-h postprandially. Appetite sensations and energy intake were registered. Gastrointestinal symptoms were monitored for 24 hours</description>
    <arm_group_label>0% pentose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Active comparator: 4% D-xylose</intervention_name>
    <arm_group_label>4% D-xylose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Active comparator: 8% D-xylose</intervention_name>
    <arm_group_label>8% D-xylose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Active comparator: 8% L-arabinose</intervention_name>
    <arm_group_label>8% L-arabinose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy males

          -  BMI between 18.4-25 kg/m2

          -  age between 18 and 30

        Exclusion Criteria:

          -  donation of blood 3 months before or during the study

          -  gastrointestinal disorders, diabetes, hypertension, hyperlipidemia, chronic infectious
             disease (HIV or hepatitis)

          -  smoking

          -  consumption of more than 21 alcoholic drinks/week

          -  elite athletes

          -  on medication
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens R Andersen, MD,MPA</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Nutrition, Exercise and Sports, University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Human Nutrition, The Royal Veterinary and Agricultural University</name>
      <address>
        <city>Frederiksberg</city>
        <zip>DK-1958</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2013</study_first_submitted>
  <study_first_submitted_qc>October 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2013</study_first_posted>
  <last_update_submitted>October 7, 2013</last_update_submitted>
  <last_update_submitted_qc>October 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>AAstrup</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>L-arabinose</keyword>
  <keyword>D-xylose</keyword>
  <keyword>sucrose</keyword>
  <keyword>glucose</keyword>
  <keyword>insulin</keyword>
  <keyword>C-peptide</keyword>
  <keyword>GLP-1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

